First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...
According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...
The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...
Susan Ringdal EVP, Strategic Planning and Global Affairs +44 (0)20 7399 2760/ +44 7776 477050 Steven Weiss US Communications +1 732 788 8279 ...
The OSHWC Code, 2020 and Social Security Code enhance worker protection in pharma through risk management, medical ...
Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive ...
Avatar: Fire & Ash stars Sam Worthington and Stephen Lang talked to us about how their characters have changed throughout the ...
This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the ...
The results showed that sac-TMT 5 mg/kg monotherapy every 2 weeks demonstrated promising antitumor activity in participants with heavily pretreated advanced or metastatic UC, with a manageable safety ...
Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback